ATE339961T1 - Chromium/biotin behandlung von dyslipidemia - Google Patents
Chromium/biotin behandlung von dyslipidemiaInfo
- Publication number
- ATE339961T1 ATE339961T1 AT02721275T AT02721275T ATE339961T1 AT E339961 T1 ATE339961 T1 AT E339961T1 AT 02721275 T AT02721275 T AT 02721275T AT 02721275 T AT02721275 T AT 02721275T AT E339961 T1 ATE339961 T1 AT E339961T1
- Authority
- AT
- Austria
- Prior art keywords
- chromium
- biotin
- dyslipidemia
- mug
- biotin treatment
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4188—1,3-Diazoles condensed with other heterocyclic ring systems, e.g. biotin, sorbinil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Inorganic Chemistry (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27188101P | 2001-02-27 | 2001-02-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE339961T1 true ATE339961T1 (de) | 2006-10-15 |
Family
ID=23037476
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02721275T ATE339961T1 (de) | 2001-02-27 | 2002-02-27 | Chromium/biotin behandlung von dyslipidemia |
Country Status (10)
Country | Link |
---|---|
US (2) | US20020197331A1 (de) |
EP (1) | EP1397148B1 (de) |
JP (1) | JP2004521127A (de) |
CN (1) | CN1512887A (de) |
AT (1) | ATE339961T1 (de) |
CA (1) | CA2438063A1 (de) |
DE (1) | DE60214849T2 (de) |
ES (1) | ES2271242T3 (de) |
PT (1) | PT1397148E (de) |
WO (1) | WO2002067953A2 (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040043106A1 (en) * | 2002-08-28 | 2004-03-04 | Anfinsen Jon R. | Methods and systems for determining and controlling glycemic responses |
US20040166181A1 (en) * | 2002-11-22 | 2004-08-26 | Shaklee Corporation | Compositions, methods, and kits for weight loss and inhibiting the loss of lean body mass |
US7744930B2 (en) * | 2002-11-22 | 2010-06-29 | Shaklee Corporation | Compositions, methods and kits for enhancing weight loss while inhibiting loss of lean body mass |
US20040180845A1 (en) * | 2003-03-13 | 2004-09-16 | Newgard Christopher B. | Methods and compositions for modulating glycogen synthesis and breakdown |
WO2007065444A1 (en) * | 2005-12-09 | 2007-06-14 | Saibot Aps | A method for evaluating the potential of a compound for use in therapy |
AU2007211625B2 (en) * | 2006-02-01 | 2012-08-23 | Nestec S.A. | Nutritional system and methods for increasing longevity |
MX2008013190A (es) | 2006-04-12 | 2009-02-10 | Interhealth Nutraceuticals Inc | Compuestos de cromo trivalente, composiciones y metodos de uso. |
TW200829178A (en) * | 2006-09-07 | 2008-07-16 | Abbott Lab | Controlled glycemic response sweetened cereal product |
US20130071491A1 (en) * | 2006-12-18 | 2013-03-21 | Jose De J. Berrios | Extruded Legume Food Products Containing Yeast Autolysate |
CA3021932C (en) * | 2007-01-31 | 2020-12-15 | Jds Therapeutics, Llc | Use of chromium histidinate for treatment of cardiometabolic disorders |
PL2134351T3 (pl) * | 2007-03-13 | 2017-10-31 | Jds Therapeutics Llc | Sposoby i kompozycje do przedłużonego uwalniania chromu |
WO2009002867A2 (en) * | 2007-06-26 | 2008-12-31 | Nutrition 21, Inc. | Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement |
CN105749253A (zh) | 2011-03-01 | 2016-07-13 | Jds治疗有限公司 | 用于预防和治疗糖尿病、低血糖症及相关病症的胰岛素和铬组合物 |
ES2395529B1 (es) * | 2011-06-08 | 2014-04-11 | Pri, S.A. | Combinación sinérgica para el tratamiento de la diabetes mellitus tipo 2. |
US20150258078A1 (en) * | 2014-03-12 | 2015-09-17 | Alexander R. Shikhman | Compositions containing berberine and pantethine and methods for treatment of lipid metabolism disorders |
US11865121B2 (en) | 2016-02-11 | 2024-01-09 | Nutrition21, LLC | Chromium containing compositions for improving health and fitness |
JP6932689B2 (ja) * | 2016-04-14 | 2021-09-08 | テーブルマーク株式会社 | 血糖値低下用又はgi値低減用の食品組成物又は組み合わせ |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US1234567A (en) * | 1915-09-14 | 1917-07-24 | Edward J Quigley | Soft collar. |
USRE33988E (en) * | 1980-08-08 | 1992-07-07 | The United States of America as repesented by the Secretary of Agriculture | Dietary supplementation with essential metal picolinates |
US4315927A (en) * | 1980-08-08 | 1982-02-16 | The United States Of America As Represented By The Secretary Of Agriculture | Dietary supplementation with essential metal picolinates |
JPS5927833A (ja) * | 1982-08-06 | 1984-02-14 | Advance Res & Dev Co Ltd | コレステロール乃至トリグリセリド低下剤 |
US4954492A (en) * | 1983-07-08 | 1990-09-04 | The William Seroy Group | Synthetic GTF chromium material for decreasing blood lipid levels and process therefor |
US5194615A (en) * | 1983-07-08 | 1993-03-16 | The William Seroy Group | Synthetic GTF chromium nicotinate material and its preparation |
US5028599A (en) * | 1986-05-15 | 1991-07-02 | Emory University | Method of treating mycardial damage |
US5032608A (en) * | 1986-09-10 | 1991-07-16 | Dudrick Stanley J | Method and substrate composition for treating atherosclerosis |
US4921877A (en) * | 1986-10-27 | 1990-05-01 | Abbott Laboratories | Liquid nutritional formula for glucose intolerance |
US5087623A (en) * | 1988-05-31 | 1992-02-11 | Nitrition 21 | Chromic picolinate treatment |
US5175156A (en) * | 1987-11-30 | 1992-12-29 | Nutrition 21 | Chromic picolinate treatment |
US6140304A (en) * | 1988-09-28 | 2000-10-31 | Eicotech Corporation | Method of and nutritional and pharmaceutical compositions for reduction of hyperinsulinemia |
US5087624A (en) * | 1989-03-21 | 1992-02-11 | Nutrition 21 | Chromic picolinate treatment |
US5106836A (en) * | 1991-02-22 | 1992-04-21 | Clintec Nutrition Co. | Enteral diet |
US5114963A (en) * | 1991-03-13 | 1992-05-19 | Medicis Corporation | Method of reducing serum levels of lipoprotein(A) |
US5597585A (en) * | 1995-12-26 | 1997-01-28 | Williams; Andrew H. | Vitamin/mineral composition |
US5937597A (en) * | 1996-07-18 | 1999-08-17 | Ykk Architectural Products Inc. | Multi-window sash and batten attachment structure |
ATE304364T1 (de) * | 1997-08-08 | 2005-09-15 | Nutrition 21 | Chromium/biotin behandlung von typ-ii diabetes |
US5789401A (en) * | 1997-08-08 | 1998-08-04 | Nutrition 21 | High-dose chromium/biotin treatment of type II diabetes |
US5914326A (en) * | 1997-08-08 | 1999-06-22 | Ambi Inc. | Method for promoting weight and fat loss |
US5948772A (en) * | 1998-08-28 | 1999-09-07 | Ambi Inc. | Chromium picolinate compositions and uses thereof |
UA77660C2 (en) * | 2000-10-03 | 2007-01-15 | Compositions and methods for reducing plasma lipoprotein a level in human | |
US6579866B2 (en) * | 2000-12-28 | 2003-06-17 | Mccleary Larry | Composition and method for modulating nutrient partitioning |
-
2002
- 2002-02-27 WO PCT/US2002/006877 patent/WO2002067953A2/en active IP Right Grant
- 2002-02-27 CA CA002438063A patent/CA2438063A1/en not_active Abandoned
- 2002-02-27 DE DE60214849T patent/DE60214849T2/de not_active Expired - Fee Related
- 2002-02-27 CN CNA02806867XA patent/CN1512887A/zh active Pending
- 2002-02-27 ES ES02721275T patent/ES2271242T3/es not_active Expired - Lifetime
- 2002-02-27 US US10/090,038 patent/US20020197331A1/en not_active Abandoned
- 2002-02-27 EP EP02721275A patent/EP1397148B1/de not_active Expired - Lifetime
- 2002-02-27 AT AT02721275T patent/ATE339961T1/de not_active IP Right Cessation
- 2002-02-27 JP JP2002567319A patent/JP2004521127A/ja active Pending
- 2002-02-27 PT PT02721275T patent/PT1397148E/pt unknown
-
2005
- 2005-05-24 US US11/136,794 patent/US20050214385A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2438063A1 (en) | 2002-09-06 |
US20050214385A1 (en) | 2005-09-29 |
DE60214849D1 (de) | 2006-11-02 |
DE60214849T2 (de) | 2007-04-26 |
EP1397148B1 (de) | 2006-09-20 |
CN1512887A (zh) | 2004-07-14 |
WO2002067953A2 (en) | 2002-09-06 |
EP1397148A2 (de) | 2004-03-17 |
JP2004521127A (ja) | 2004-07-15 |
PT1397148E (pt) | 2006-11-30 |
WO2002067953A3 (en) | 2002-11-21 |
ES2271242T3 (es) | 2007-04-16 |
US20020197331A1 (en) | 2002-12-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE339961T1 (de) | Chromium/biotin behandlung von dyslipidemia | |
IL157821A0 (en) | Treatment of type 2 diabetes with inhibitors of dipeptidyl peptidase iv | |
PT1056856E (pt) | Factor neurotrofico cliliar modificado processo de preparacao e sua utilizacao | |
BR9712523A (pt) | Novos derivados de pirazol heterociclilmetil-substituìdos | |
EP1576956A3 (de) | Chromium/Biotin Behandlung von Typ-II Diabetes | |
ES2184808T3 (es) | Tratamiento de la esclerosis multiple (em) y otro estados desmielinizantes empleando lofepramina en combinacion con l-fenilalanina, tirosina o triptofano y opcionalmente un compuesto de vitamina b12. | |
DE69831576T2 (de) | Chromium/biotin behandlung von typ-ii diabetes | |
BRPI0409716A (pt) | derivados de 2-acilamino-4-feniltiazol, seu preparo e sua aplicação em terapêutica | |
BRPI0009719B8 (pt) | processo de tratamento | |
WO2000059487A3 (en) | Flupirtine in the treatment of fibromyalgia and related conditions | |
NZ516349A (en) | Conjugates of phytosterol or phytostanol with ascorbic acid and use thereof in treating or preventing cardiovascular disease | |
SE9101815D0 (sv) | Behandling av sjukdom foerbunden med hiv-infektioner | |
BR0115045A (pt) | Compostos, processo para sua preparação, composição farmacêutica que compreende os mesmos, sua utilização, processo para o tratamento e profilaxia de artrite, diabetes, distúrbios alimentares e obesidade | |
RS8504A (en) | Novel cyclohexil sulphones | |
WO2001072322A3 (en) | High dosage parenteral administration of lactoferrin | |
ATE252383T1 (de) | Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen | |
EP1447090B8 (de) | Verwendung von Hyaluronidase zur Prophylaxe und Behandlung von Herz-Kreislauf-Erkrankungen | |
ATE305796T1 (de) | Präparationen von vitamin e in kombination mit afamin | |
DE60216292D1 (de) | Calciumtrifluoracetat mit zytotoxischer wirkung | |
PL367630A1 (en) | Use of acetyl l-carnitine in association with the biotin for the treatment of patients with type 2 insulin-resistant diabetes mellitus | |
Roberts | A New Root for an Old Crux, Ps. XXII 17c | |
TH23084A (th) | วิธีของการรักษา | |
RU98113874A (ru) | Способ лечения угревой болезни у женщин | |
ATE334675T1 (de) | Arzneimittel enthaltend substituierte 2,5- diaminomethyl-1h-pyrrole | |
DK1032407T3 (da) | Anvendelse af putamen ovi |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1397148 Country of ref document: EP |
|
REN | Ceased due to non-payment of the annual fee |